An update from Sintx Technologies ( (SINT) ) is now available.
On April 3, 2025, Sintx Technologies, Inc. appointed five new directors to its Board: Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons, and Gregg Honigblum. Each director brings extensive experience in the life sciences and medical device industries, which is expected to enhance the company’s strategic direction. Concurrently, previous directors B. Sonny Bal, David Truetzel, Jeffrey White, Eric Stookey, and Mark Froimson resigned, with their departures not attributed to any disagreements with the company.
Spark’s Take on SINT Stock
According to Spark, TipRanks’ AI Analyst, SINT is a Neutral.
Sintx Technologies struggles with financial and operational challenges, evident in its negative profitability and cash flow issues. The technical indicators suggest a bearish sentiment, while its valuation metrics are weak due to ongoing losses. These factors collectively contribute to a low overall stock score.
To see Spark’s full report on SINT stock, click here.
More about Sintx Technologies
YTD Price Performance: -42.47%
Average Trading Volume: 1,359,379
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.18M
Learn more about SINT stock on TipRanks’ Stock Analysis page.